Associated Papers
Clinical and Genetic Characterization of 51 Patients with Congenital Fibrinogen Disorders from China.
Cai Y et al.
Thrombosis and Haemostasis, 2025
Genetic mutations associated with congenital fibrinogen disorders: global distribution and clinical outcomes.
Nóbrega T et al.
Journal of Thrombosis and Thrombolysis, 2025
Integrating Next-Generation Sequencing Into Routine Molecular Diagnosis of Inherited Coagulation Factor Deficiencies: Real-World Data From Spanish Patients.
Borràs N et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia, 2025
40577417 (PubMed )
Supplement: HAE-31-734-s001.pdf
Variants leading to dysfibrinogenaemia in the fibrinogen α-chain at residue Arg19 are not solely associated with bleeding, but also with thrombotic events.
Bor MV
British Journal of Haematology, 2024
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database.
Mohsenian S et al.
Blood Advances, 2024
Congenital fibrinogen disorders: Strengthening genotype-phenotype correlations through novel genetic diagnostic tools.
Ramanan R et al.
British Journal of Haematology, 2023
Dysfibrinogenemia-Potential Impact of Genotype on Thrombosis or Bleeding.
Bor MV et al.
Seminars in Thrombosis and Hemostasis, 2022
[Analysis of gene mutation spectrum and pharmacokinetics of fibrinogen infusion in 146 cases of congenital fibrinogen disorders].
Huang LY et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi, 2021
Risk of bleeding and thrombosis in inherited qualitative fibrinogen disorders.
Castaman G et al.
European Journal of Haematology, 2019
Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation.
Asselta R et al.
Thrombosis Research, 2015
Clinical proteome informatics workbench detects pathogenic mutations in hereditary amyloidoses.
Dasari S et al.
Journal of Proteome Research, 2014
24650283 (PubMed )
Supplement: pr4011475_si_001.pdf
Congenital fibrinogen disorders: an update.
de Moerloose P et al.
Seminars in Thrombosis and Hemostasis, 2013
Treatment of congenital fibrinogen disorders.
de Moerloose P et al.
Expert Opinion on Biological Therapy, 2008
Select a paper to view details